VR Logo

Unrated

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan


1 Lakh

Investment Grown to
₹ 1.23 Lakh

₹ 10000

Monthly SIP Grown to
₹ 1.30 Lakh

Suitability:

This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.

We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.

But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.

Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.

Taxability of earnings:

Capital gains

  • If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1 lakh in a financial year are exempt from tax. Gains over Rs 1 lakh are taxed at the rate of 10%.
  • If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 15%.
  • No tax is to be paid as long as you continue to hold the units.

Dividends

  • Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 5,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Read more

ajax-loader
Please wait...

ajax-loader
Please wait...

(₹)
cal
cal

ajax-loader
Please wait...

Trailing Returns (%)

YTD 1-Day 1-W 1-M 3-M 6-M 1-Y 3-Y 5-Y 7-Y 10-Y
Fund 15.18 2.54 1.67 1.97 0.29 5.80 23.45 -- -- -- --
S&P BSE Healthcare TRI 18.85 1.18 1.76 1.72 0.15 4.09 28.05 -- -- -- --
Equity: Sectoral-Pharma 16.87 1.43 1.61 1.00 0.00 4.37 25.81 -- -- -- --
Rank within category 7 1 8 5 6 3 8 -- -- -- --
Number of funds in category 10 15 15 14 13 12 10 6 4 3 3

As on 26-Nov-2021

Peer Comparison

Fund name Rating Launch Date 1-Year Return 3-Year Return 5-Year Return Expense Ratio Assets (Cr)
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund - Regular Plan  | Invest Online
Unrated
Oct-20 23.45 -- -- 1.06% 190
Nippon India Pharma Fund
Unrated
Jun-04 30.05 26.42 16.44 1.89% 5,210
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund  | Invest Now
Unrated
Jul-18 25.55 26.91 -- 1.99% 3,045
SBI Healthcare Opportunities Fund  | Invest Online
Unrated
Jul-99 23.43 23.41 10.29 2.11% 1,872
Mirae Asset Healthcare Fund - Regular Plan  | Invest Online
Unrated
Jul-18 33.23 31.21 -- 2.08% 1,798

Best & Worst Performance

Best Performance Worst Performance
Return (%) Period Return (%) Period
Week 4.69 01-Apr-2021 - 09-Apr-2021 -4.69 16-Feb-2021 - 23-Feb-2021
Month 12.37 19-Mar-2021 - 20-Apr-2021 -6.75 16-Feb-2021 - 18-Mar-2021
Quarter 17.48 18-Mar-2021 - 17-Jun-2021 -4.81 17-Dec-2020 - 18-Mar-2021
Year 25.78 02-Nov-2020 - 02-Nov-2021 18.62 24-Nov-2020 - 24-Nov-2021

Risk Measures (%)

Mean Std Dev Sharpe Sortino Beta Alpha
Fund -- -- -- -- -- --
S&P BSE Healthcare TRI* 20.65 21.78 0.77 1.72 -- --
Equity: Sectoral-Pharma* 24.08 19.88 1.02 2.31 0.89 5.21
Rank within category -- -- -- -- -- --
Number of funds in category -- -- -- -- -- --

The Risk Measures have been calculated using calendar month returns for the last three years.

As on

* As on 31-Oct-2021

Asset Allocation (%)

ajax-loader
Please wait...

Concentration & Valuation

Number of Stocks 44
Top 10 Stocks (%) 51.68
Top 5 Stocks (%) 39.25
Top 3 Sectors (%) 96.37
Portfolio P/B Ratio 64.57
Portfolio P/E Ratio 428.65

Portfolio Aggregates

Fund Category
Average Mkt Cap (Rs Cr) 1,12,312 56,104
Giant (%) 30.66 15.64
Large (%) 37.45 41.83
Mid (%) 30.58 35.12
Small (%) 1.32 7.40
Tiny (%) -- --

Value Research Fund Style

Sector Allocation vis-à-vis Category

ajax-loader
Please wait...

Top Holdings

Company Sector P/E 3Y High 3Y Low % Assets
up Divi's Laboratories Healthcare 61.32 9.72 0.00 9.72
down Sun Pharmaceutical Industries Healthcare 29.53 9.79 0.00 9.49
up Dr. Reddy's Lab Healthcare 40.25 9.96 0.00 7.71
up Cipla Healthcare 30.12 6.94 0.00 6.23
up Apollo Hospitals Healthcare 78.32 6.83 0.00 6.10
up Johnson & Johnson Diversified -- 4.48
up Lupin Healthcare -- 4.30 0.00 2.98
up Aurobindo Pharma Healthcare 7.62 4.59 0.00 2.87
up Thermo Fisher Scientific Inc Chemicals -- 2.60
up Pfizer INC Healthcare -- 2.56
up Abbott Laboratories Healthcare -- 2.39
up Laurus Labs Healthcare 27.73 3.27 0.00 2.36
up Merck & Co Inc (US) Healthcare -- 2.33
up Ipca Laboratories Healthcare 26.00 2.65 0.00 2.12
up AbbVie Inc Healthcare -- 2.12
up Biocon Healthcare 67.56 3.21 0.00 2.10
up Danaher Corporation FMCG -- 2.09
up Torrent Pharmaceuticals Healthcare 40.07 2.34 0.00 2.06
up Novartis AG (ADS/ADR) Healthcare -- 1.92
up Medtronic Healthcare -- 1.69
up Dr. Lal Pathlabs Healthcare 75.38 1.83 0.00 1.65
up Fortis Healthcare Healthcare 48.38 1.80 0.00 1.57
up Abbott India Healthcare 57.34 1.53 0.00 1.51
up Max Healthcare Institute Healthcare 79.73 1.53 0.00 1.37
up Bristol-Myers Squibb Co Healthcare -- 1.36

up down equal Indicates an increase or decrease or no change in holding since last portfolio
new Indicates a new holding since last portfolio

As on 31-Oct-2021

Fund Manager

— Bhavesh Jain since 01-Oct-2021

Education: Mr. Jain is a MMS (Finance) from Mumbai University.

Experience: Prior to joining Edelweiss Mutual Fund he was previously associated with Edelweiss Securities Limited as SGX Nifty Arbitrage Trader.

Funds Managed:


2.54%

Change from previous, NAV as on 26-Nov-2021

Growth: ₹ 12.7486

IDCW: ₹ 12.7486


Investment Strategy

The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.

Investment Details

Minimum Investment (₹) 5,000
Minimum Addl Investment (₹) 500
Minimum SIP Investment (₹) 500
Minimum No of Cheques 12
Minimum Withdrawal (₹) 500
Minimum Balance (₹) --
Lock-in Period Not Applicable
Exit Load 0

Basic Details

Fund House: Edelweiss Mutual Fund
Launch Date: 26-Oct-2020
Return Since Launch: 25.09%
Benchmark: MSCI India Domestic & World HC 45 Index
Riskometer: Very High
Type: Open-ended
Assets: ₹ 190 Cr (As on 31-Oct-2021)
Expense: 1.06% (As on 31-Oct-2021)
Risk Grade: --
Return Grade: --
Turnover: --

Contact Information

AMC: Edelweiss Asset Management Ltd.

Address: 801- 802 & 803 - 8th Floor, Windsor Off C.S.T. Road, Kalina-Santacruz (E), Mumbai - 400098

Phone: 40933400 / 1800-425-0090

Email: [email protected]

Website: http://www.edelweissmf.com

Registrar & Transfer Agent: KFin Technologies Pvt Ltd.

Address: 303, Vamsee Estates, Opp. Big Bazaar, Ameerpet, Hyderabad - 500016

Phone: 040-44857874

Email: [email protected]

Website: www.karvymfs.com

Upcoming Video

Investors' Hangout

Stocks or Equity Funds for the long term?

DateFriday, 10-Dec-2021
Time12:30 PM - 01:00 PM

attending You have reserved a spot